11716 GENES FOUND
Show / hide columns
XML |
RDF |
TSV |
Page next »
IH abundance (Normal Tissue)
x
RNA abundance (Normal Tissue)
x
A4GALT Alpha 1,4-galactosyltransferase
Mitochondria Cervical cancer: 2.48e-4 Mixed
AAAS Achalasia, adrenocortical insufficiency, alacrimia
Nuclear membrane Renal cancer: 2.93e-4 Expressed in all
AACS Acetoacetyl-CoA synthetase
Vesicles Expressed in all
AADAT Aminoadipate aminotransferase
Vesicles Colorectal cancer: 5.59e-4 Tissue enhanced liver: 34.6
AAED1 AhpC/TSA antioxidant enzyme domain containing 1
Renal cancer: 3.26e-5 Expressed in all
AAGAB Alpha- and gamma-adaptin binding protein
Nuclear speckles Renal cancer: 1.36e-4 Thyroid cancer: 9.48e-4 Expressed in all
AAK1 AP2 associated kinase 1
Plasma membrane Ovarian cancer: 3.19e-4 Tissue enriched 6 parathyroid gland: 382.6
AAMDC Adipogenesis associated, Mth938 domain containing
Nucleoplasm Expressed in all
AAMP Angio-associated, migratory cell protein
Microtubules Liver cancer: 4.94e-7 Endometrial cancer: 1.62e-4 Expressed in all
AAR2 AAR2 splicing factor homolog N/A
Cytosol Liver cancer: 1.83e-6 Expressed in all
AARS Alanyl-tRNA synthetase
Cytosol Expressed in all
AARS2 Alanyl-tRNA synthetase 2, mitochondrial
Mitochondria Mixed
AARSD1 Alanyl-tRNA synthetase domain containing 1
Nuclear membrane Renal cancer: 1.67e-6 Expressed in all
AASDH Aminoadipate-semialdehyde dehydrogenase
Mixed
AASDHPPT Aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase
Mitochondria Renal cancer: 4.27e-4 Expressed in all
AASS Aminoadipate-semialdehyde synthase
Vesicles Liver cancer: 9.81e-4 Mixed
AATF Apoptosis antagonizing transcription factor
Renal cancer: 4.14e-5 Liver cancer: 6.62e-5 Expressed in all
ABCA1 ATP-binding cassette, sub-family A (ABC1), member 1
Nucleoplasm Mixed
ABCA2 ATP-binding cassette, sub-family A (ABC1), member 2
Tissue enriched 6 cerebral cortex: 98.2
ABCA3 ATP-binding cassette, sub-family A (ABC1), member 3
Nucleoplasm Tissue enhanced lung: 135.8
ABCA5 ATP-binding cassette, sub-family A (ABC1), member 5
Pancreatic cancer: 9.97e-5 Expressed in all
ABCA7 ATP-binding cassette, sub-family A (ABC1), member 7
Golgi apparatus Endometrial cancer: 1.12e-4 Colorectal cancer: 7.26e-4 Mixed
ABCB10 ATP-binding cassette, sub-family B (MDR/TAP), member 10
Expressed in all
ABCB6 ATP-binding cassette, sub-family B (MDR/TAP), member 6 (Langereis blood group)
Nucleoplasm Renal cancer: 1.52e-7 Liver cancer: 9.45e-7 Expressed in all
ABCB7 ATP-binding cassette, sub-family B (MDR/TAP), member 7
Mitochondria Renal cancer: 5.31e-6 Expressed in all
ABCB8 ATP-binding cassette, sub-family B (MDR/TAP), member 8
Nucleus Pancreatic cancer: 3.34e-4 Renal cancer: 5.88e-4 Head and neck cancer: 5.91e-4 Expressed in all
ABCB9 ATP-binding cassette, sub-family B (MDR/TAP), member 9
Vesicles Glioma: 4.62e-4 Tissue enhanced testis: 23.9
ABCC1 ATP-binding cassette, sub-family C (CFTR/MRP), member 1
Plasma membrane Renal cancer: 1.55e-6 Liver cancer: 5.42e-5 Mixed
ABCC10 ATP-binding cassette, sub-family C (CFTR/MRP), member 10
Renal cancer: 1.90e-4 Expressed in all
ABCC4 ATP-binding cassette, sub-family C (CFTR/MRP), member 4
Nucleoli Renal cancer: 2.25e-10 Endometrial cancer: 9.89e-4 Tissue enhanced prostate: 68.5
ABCC5 ATP-binding cassette, sub-family C (CFTR/MRP), member 5
Nucleus Liver cancer: 6.78e-8 Prostate cancer: 3.40e-4 Expressed in all
ABCC6 ATP-binding cassette, sub-family C (CFTR/MRP), member 6
Plasma membrane Liver cancer: 3.82e-4 Tissue enhanced kidney: 15.2 liver: 19.1
ABCC9 ATP-binding cassette, sub-family C (CFTR/MRP), member 9
Nucleoplasm Renal cancer: 1.85e-5 Mixed
ABCD1 ATP-binding cassette, sub-family D (ALD), member 1
Renal cancer: 5.50e-4 Expressed in all
ABCD3 ATP-binding cassette, sub-family D (ALD), member 3
Peroxisomes Colorectal cancer: 1.16e-5 Renal cancer: 4.84e-5 Expressed in all
ABCD4 ATP-binding cassette, sub-family D (ALD), member 4
Expressed in all
ABCE1 ATP-binding cassette, sub-family E (OABP), member 1
Cytosol Pancreatic cancer: 1.88e-4 Liver cancer: 6.29e-4 Colorectal cancer: 8.69e-4 Expressed in all
ABCF1 ATP-binding cassette, sub-family F (GCN20), member 1
Cytosol Liver cancer: 9.47e-4 Mixed
ABCF2 ATP-binding cassette, sub-family F (GCN20), member 2
Cytosol Liver cancer: 9.52e-6 Expressed in all
ABCF3 ATP-binding cassette, sub-family F (GCN20), member 3
Nucleoli Liver cancer: 4.16e-5 Expressed in all
ABCG2 ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
Nucleus Tissue enhanced small intestine: 116.1
ABHD10 Abhydrolase domain containing 10
Mitochondria Renal cancer: 4.72e-9 Cervical cancer: 7.57e-4 Expressed in all
ABHD11 Abhydrolase domain containing 11
Mitochondria Renal cancer: 3.66e-7 Expressed in all
ABHD12 Abhydrolase domain containing 12
Cervical cancer: 1.30e-5 Breast cancer: 3.81e-5 Liver cancer: 7.18e-4 Expressed in all
ABHD13 Abhydrolase domain containing 13
Cytosol Mixed
ABHD14A Abhydrolase domain containing 14A
Vesicles Lung cancer: 4.72e-4 Expressed in all
ABHD14B Abhydrolase domain containing 14B
Nucleus Renal cancer: 2.93e-5 Endometrial cancer: 5.42e-5 Cervical cancer: 6.92e-5 Expressed in all
ABHD15 Abhydrolase domain containing 15
Nucleoplasm Mixed
ABHD16A Abhydrolase domain containing 16A
Endometrial cancer: 2.63e-4 Tissue enhanced gallbladder: 1.7 testis: 1.3 thyroid gland: 1.3
ABHD16B Abhydrolase domain containing 16B N/A
Nucleoplasm Mixed
Page next »
